| Name | CBP/p300-IN-15 |
|---|---|
| Synonyms | Urea, N-[(1R)-2,3-dihydro-2',4'-dioxo-3'-[2-oxo-2-[(3R)-1,3,4,5-tetrahydro-3-methyl-2H-2-benzazin-2-yl]ethyl]spiro[1H-indene-1,5'-oxazolidin]-5-yl]-N'-methyl |
| Description | CBP/p300-IN-15 (compound 13a) is a potent p300/CBP inhibitor, with IC50 values of 2.50 and 28.0 nM, respectively. CBP/p300-IN-15 shows good activity against OVCAR-3 and A2780 cell line, with EC50 values of 0.865 and 2.71 μM, respectively. CBP/p300-IN-15 can be used for ovarian cancer research[1]. |
|---|---|
| Related Catalog | |
| Target |
CBP:28.0 nM (IC50) p300:2.50 nM (IC50) |
| References |
| Molecular Formula | C26H28N4O5 |
|---|---|
| Molecular Weight | 476.52 |